발 및 발목용 기기 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the foot and ankle devices market size is expected to grow from USD 5.48 billion in 2025 to USD 5.48 billion in 2026 and is forecast to reach USD 8.27 billion by 2031 at 7.09% CAGR over 2026-2031.

This report is Segmented by Product Type (Orthopedic Fixation Devices, and More), Application (Trauma & Fractures, and More), End-User (Hospitals, Ambulatory Surgical Centers, Specialty Orthopedic/Podiatric Clinics, and Rehabilitation Centers), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The Market Forecasts are Provided in Terms of Value (USD).

Global Foot And Ankle Devices Market Trends and Insights

Growing Surgical Volume from Trauma and Degenerative Conditions

Trauma and degenerative pathologies together drive more than half of all device demand, and fracture care alone represented 36.8% of 2025 applications. Vehicle collisions, sports injuries, and workplace accidents fuel high-energy ankle fractures in younger adults, while fragile bones amplify fracture rates in seniors living longer with osteoporosis. Surgeons increasingly favor minimally invasive fixation, locking plates, and revision-friendly nails that permit earlier weight bearing and faster rehabilitation. Registry data from 2025 confirmed that anatomic plating improved alignment and reduced nonunion rates compared with conventional constructs. Launches such as Zimmer Biomet's Gorilla Pilon Fusion Plating System illustrate how companies refine hardware geometry for comminuted injuries and arthrodesis requirements. The steady rise of joint-preserving options delays end-stage arthrodesis, enlarging the long-term procedure pool.

Technological Advancements in Implant Materials and Digital Surgery

Regulatory clarity for patient-matched implants is accelerating adoption of 3D-printed titanium and cobalt-chromium constructs that mirror a patient's bone contours. Porous lattices foster osseointegration, while single-use guides shave minutes off operative time. Clearance of Paragon 28's APEX 3D Total Ankle System in 2024 validated the speed with which smaller firms can translate additive manufacturing into commercial products. Digital platforms overlay navigation cues in surgeons' field of view; Johnson & Johnson's VOLT mini plating system pairs with augmented-reality headsets to perfect screw trajectories. Sensor-enabled implants such as Canary Medical's Canturio TE stream real-time load data to cloud dashboards, supporting tele-rehabilitation and early warning of loosening. Standardization bodies, notably ASTM F3001, now guide non-destructive testing routines that flag micro-porosity and prevent fatigue failure.

High Treatment Cost and Limited Reimbursement in Emerging Markets

Self-payment remains dominant in much of South Asia, Africa, and parts of Latin America, where per capita health outlays are below USD 600. Implant packages for total ankle arthroplasty can exceed USD 8,000 before facility and surgeon fees, pushing procedures out of reach for most households. India's Ayushman Bharat scheme reimburses catastrophic care but caps implant pricing, compelling many patients to downgrade to basic stainless-steel systems or forgo surgery. Private insurance penetration below 5% across several emerging economies slows the uptake of premium prostheses and digital instrumentation. Tiered product families help vendors address cost pressure, but fragmented pricing complicates forecasting and inventory management.

Other drivers and restraints analyzed in the detailed report include:

1. Migration of Procedures to Ambulatory Surgery Centers
2. Rising Global Geriatric and Obese Population
3. Stringent Global Regulatory and Post-Market Surveillance Requirements

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Prostheses opened 2026 with 32.9% revenue and are projected to post a 9.5% CAGR to 2031, making them the strongest contributor to the foot and ankle devices market. High-end microprocessor ankles, such as Ossur's 2024 Proprio Foot, adjust joint angles in real time, lowering metabolic cost by up to 15% and enabling stair ambulation without compensatory hip swing. Orthopedic reconstruction implants secure a 32.5% share, yet their growth moderates as surgeons debate ten-year survivorship, which still trails hip and knee analogs by roughly 80%. Fixation hardware remains essential for complex fractures, with variable-angle plates and percutaneous nails facilitating soft-tissue-gentle techniques that quicken rehabilitation. The foot and ankle devices market size for fixation solutions is projected to reach USD 2.7 billion by 2031 at a 6.2% CAGR. Bracing, supports, and bio-scaffolds occupy smaller but rising niches as demand for ligament repair and cartilage preservation mounts.

A push toward patient-matched constructs is visible across all subcategories. Electron-beam melting and laser-powder bed fusion create porous geometries that are impossible to achieve with machining, enhancing osteointegration and distributing load more evenly across reconstructed joints. Regulatory acceptance is widening: the FDA cleared five patient-matched ankle constructs in 2025 alone, twice as many as in 2023. Vendors now ship single-use cutting guides with QR-coded sterilization logs, aligning with ambulatory center preferences for disposable instrumentation that curbs reprocessing overhead.

Complete Report Scope:

• By Product Type
  • Orthopedic Fixation Devices
  • Orthopedic Implants (Joint & Fusion)
  • Bracing & Support Devices
  • Prostheses
  • Soft-Tissue Orthopedic Devices
• By Application
  • Trauma & Fractures
  • Osteoarthritis & Rheumatoid Arthritis
  • Diabetic Foot Disorders
  • Neurological & Congenital Disorders
  • Sports-Related Injuries & Others
• By End-User
  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Orthopedic / Podiatric Clinics
  • Rehabilitation Centers
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 43.2% of 2025 sales, driven by Medicare-backed outpatient migration and the rapid adoption of patient-matched hardware. FDA guidance issued in 2024 clarified additive manufacturing file requirements, accelerating clearances for complex hindfoot cages that cut operative time by 20%. U.S. private insurers followed CMS's lead, expanding ambulatory surgery center coverage for ankle arthroplasty in their 2026 policies. Canadian provinces pooled procurement for standard trauma plates, slimming system costs, while Mexico's private hospitals marketed premium reconstructions to inbound medical tourists from Central America.

Asia-Pacific is projected to record the fastest regional CAGR at 8.5% through 2031. China's 14th Five-Year Plan prioritizes community trauma centers, and provincial tenders in 2026 favored vendors offering training packages with navigation units. India's Health Mission funded digital radiography suites and navigation modules for 150 district hospitals in 2025, opening rural corridors previously underserved[3]. Japan's super-aged demographic escalated ankle fracture admissions 11% year-on-year in 2025, prompting insurers to raise arthrodesis reimbursement. Australia's robust private coverage underwrites early adoption of smart implants, while Korean surgeons pioneer mixed-reality navigation in hindfoot fusions supported by government innovation grants.

Europe and South America delivered mid-single-digit expansion. EU Medical Device Regulation compliance costs delayed several small-company launches but reinforced patient safety and opened consortium opportunities for real-world registries. Germany and France awarded multi-year bulk tenders in 2025 that bundled trauma and diabetic foot constructs, stabilizing prices but reducing vendor count. In the United Kingdom, National Health Service wait lists for complex reconstructions exceeded 12 months in late 2025, pushing some patients onto private pathways that offer quicker access to high-end implants. Brazil and Argentina led South American demand; fluctuating exchange rates added procurement risk, so hospitals negotiated installment contracts in USD to secure 2026 deliveries.

1. Acumed
2. Advanced Orthopaedic Solutions
3. Arthrex
4. Conmed
5. Enovis (Formerly DJO)
6. Extremity Medical LLC
7. Integra LifeSciences
8. Johnson & Johnson
9. Medartis
10. MiRus LLC
11. Orthofix
12. Ottobock
13. Paragon 28
14. Smiths Group
15. Stryker
16. Wright Medical Group
17. Zimmer Biomet

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope Of The Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Surgical Volume from Trauma and Degenerative Conditions
  • 4.2.2 Technological Advancements in Implant Materials and Digital Surgery
  • 4.2.3 Migration of Procedures to Ambulatory Surgery Centers
  • 4.2.4 Rising Global Geriatric and Obese Population
  • 4.2.5 Emergence of Bio-Scaffold and Regenerative Solutions
  • 4.2.6 Integration of Smart Implants and Remote Monitoring
• 4.3 Market Restraints
  • 4.3.1 High Treatment Cost and Limited Reimbursement in Emerging Markets
  • 4.3.2 Stringent Global Regulatory and Post-Market Surveillance Requirements
  • 4.3.3 Clinical Concerns Over Implant Longevity and Revision Risk
  • 4.3.4 Manufacturing Quality Challenges in Additive and Customized Implants
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat Of New Entrants
  • 4.7.2 Bargaining Power Of Buyers
  • 4.7.3 Bargaining Power Of Suppliers
  • 4.7.4 Threat Of Substitutes
  • 4.7.5 Intensity Of Competitive Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Product Type
  • 5.1.1 Orthopedic Fixation Devices
  • 5.1.2 Orthopedic Implants (Joint & Fusion)
  • 5.1.3 Bracing & Support Devices
  • 5.1.4 Prostheses
  • 5.1.5 Soft-Tissue Orthopedic Devices
• 5.2 By Application
  • 5.2.1 Trauma & Fractures
  • 5.2.2 Osteoarthritis & Rheumatoid Arthritis
  • 5.2.3 Diabetic Foot Disorders
  • 5.2.4 Neurological & Congenital Disorders
  • 5.2.5 Sports-Related Injuries & Others
• 5.3 By End-User
  • 5.3.1 Hospitals
  • 5.3.2 Ambulatory Surgical Centers (ASCs)
  • 5.3.3 Specialty Orthopedic / Podiatric Clinics
  • 5.3.4 Rehabilitation Centers
• 5.4 Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
  • 5.4.4 Middle East & Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East & Africa
  • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (Includes Global-Level Overview, Market-Level Overview, Core Segments, Financials As Available, Strategic Information, Market Rank/Share For Key Companies, Products & Services, And Recent Developments)
  • 6.3.1 Acumed LLC
  • 6.3.2 Advanced Orthopaedic Solutions
  • 6.3.3 Arthrex Inc.
  • 6.3.4 CONMED Corporation
  • 6.3.5 Enovis (Formerly DJO)
  • 6.3.6 Extremity Medical LLC
  • 6.3.7 Integra LifeSciences
  • 6.3.8 Johnson & Johnson (DePuy Synthes)
  • 6.3.9 Medartis AG
  • 6.3.10 MiRus LLC
  • 6.3.11 Orthofix Medical Inc.
  • 6.3.12 Ottobock SE & Co. KGaA
  • 6.3.13 Paragon 28
  • 6.3.14 Smith & Nephew PLC
  • 6.3.15 Stryker Corporation
  • 6.3.16 Wright Medical Group NV
  • 6.3.17 Zimmer Biomet

7 Market Opportunities & Future Outlook

• 7.1 White-Space & Unmet-Need Assessment